{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:54:03Z","timestamp":1785772443336,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:00:00Z","timestamp":1794960000000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000124","name":"National Institutes of Health Office of Research on Women's Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jtha.2025.08.012","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:49:26Z","timestamp":1756482566000},"page":"3809-3817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Interdisciplinary management of gynecologic bleeding with anticoagulation: a recommended toolkit from the Foundation for Women and Girls with Blood Disorders+ Thrombosis Subcommittee"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9981-8990","authenticated-orcid":false,"given":"Bethany","family":"Samuelson Bannow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhvi","family":"Rajpurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilmarie","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divyaswathi","family":"Citla-Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi V.","family":"Srivaths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.08.012_bib1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4274\/jcrpe.galenos.2023.2022-10-7","article-title":"Evaluation of abnormal uterine bleeding in adolescents: single center experience","volume":"15","author":"K\u0131z\u0131lcan \u00c7etin","year":"2023","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.jtha.2025.08.012_bib2","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.thromres.2013.04.034","article-title":"Postpartum wound and bleeding complications in women who received peripartum anticoagulation","volume":"132","author":"Limmer","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.08.012_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/jamapediatrics.2019.5040","article-title":"Diagnosis and management of heavy menstrual bleeding and bleeding disorders in adolescents","volume":"174","author":"Borzutzky","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jtha.2025.08.012_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2020.11.014","article-title":"Heavy menstrual bleeding in women on oral anticoagulants","volume":"197","author":"Samuelson Bannow","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.08.012_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12763","article-title":"Hormonal therapies and venous thrombosis: considerations for prevention and management","volume":"6","author":"LaVasseur","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.012_bib6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.vph.2016.11.003","article-title":"Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism","volume":"87","author":"Bryk","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jtha.2025.08.012_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.001","article-title":"Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism","volume":"93-95","author":"Godin","year":"2017","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jtha.2025.08.012_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.thromres.2017.11.019","article-title":"A multi-institutional registry of pediatric hospital-acquired thrombosis cases: the Children\u2019s Hospital-Acquired Thrombosis (CHAT) project","volume":"161","author":"Jaffray","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.08.012_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1440-1754.2011.02101.x","article-title":"Effect of warfarin on menstruation and menstrual management of the adolescent on warfarin","volume":"47","author":"Peake","year":"2011","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jtha.2025.08.012_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpag.2017.12.007","article-title":"Gynecologic bleeding complications in postmenarchal female adolescents receiving antithrombotic medications","volume":"31","author":"Soni","year":"2018","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jtha.2025.08.012_bib11","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1182\/blood.2022017101","article-title":"Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism","volume":"140","author":"de Jong","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.012_bib12","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.08.012_bib13","article-title":"Direct oral anticoagulants in pediatric venous thromboembolism: experience in specialized pediatric hemostasis centers in the United States","volume":"7","author":"Corrales-Medina","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.012_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30926","article-title":"Real-world experience of direct oral anticoagulant use in a single pediatric center","volume":"71","author":"Valenti","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtha.2025.08.012_bib15","first-page":"52","article-title":"Recurrent haemorrhagic ovarian cyst and anticoagulant therapy: a case report with review of treatment modalities","volume":"40","author":"Nagandla","year":"2021","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.jtha.2025.08.012_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12570","article-title":"Menstruation, anticoagulation, and contraception: VTE and uterine bleeding","volume":"5","author":"Samuelson Bannow","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.012_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/hematology.2020000166","article-title":"Abnormal uterine bleeding in users of rivaroxaban and apixaban","volume":"2020","author":"Jacobson-Kelly","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2025.08.012_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1182\/hematology.2020000138","article-title":"Management of heavy menstrual bleeding on anticoagulation","volume":"2020","author":"Samuelson Bannow","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2025.08.012_bib19","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jtha.2024.04.002","article-title":"Management of abnormal uterine bleeding on anticoagulation: the patient-clinician perspective","volume":"22","author":"Samuelson Bannow","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.012_bib20","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jtha.2023.03.015","article-title":"Multidisciplinary care of the pregnant patient with or at risk for venous thromboembolism: a recommended toolkit from the Foundation for Women and Girls with Blood Disorders Thrombosis Subcommittee","volume":"21","author":"Samuelson Bannow","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.012_bib21","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.08.012_bib22","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/jth.13366","article-title":"Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH","volume":"14","author":"Cohen","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.012_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1542\/peds.2010-2221","article-title":"Hormonal contraception and thrombotic risk: a multidisciplinary approach","volume":"127","author":"Trenor","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jtha.2025.08.012_bib24","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.012_bib25","first-page":"677","article-title":"Combined hormonal contraceptives for heavy menstrual bleeding","volume":"100","author":"Singh","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jtha.2025.08.012_bib26","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.fertnstert.2011.03.079","article-title":"The FIGO classification of causes of abnormal uterine bleeding in the reproductive years","volume":"95","author":"Munro","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jtha.2025.08.012_bib27","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1152\/physrev.00031.2019","article-title":"Physiology of the endometrium and regulation of menstruation","volume":"100","author":"Critchley","year":"2020","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jtha.2025.08.012_bib28","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.012_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/hae.12836","article-title":"Developing a multidisciplinary Young Women\u2019s Blood Disorders Program: a single-centre approach with guidance for other centres","volume":"22","author":"Zia","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.08.012_bib30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1182\/hematology.2024000562","article-title":"Heavy menstrual bleeding clinics for adolescents","volume":"2024","author":"Baldwin","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2025.08.012_bib31","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1182\/blood.V122.21.4772.4772","article-title":"Establishment of a reference range for the PBAC-score","volume":"122","author":"Halimeh","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.012_bib32","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jtha.2025.08.012_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102448","article-title":"Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial","volume":"8","author":"Hamuly\u00e1k","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.012_bib34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/rth2.12474","article-title":"Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: comparison of high- and low-dose rivaroxaban with aspirin","volume":"5","author":"Boonyawat","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.012_bib35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.thromres.2015.07.030","article-title":"Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists","volume":"136","author":"De Crem","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.08.012_bib36","doi-asserted-by":"crossref","first-page":"e1775","DOI":"10.1016\/S2214-109X(23)00416-3","article-title":"Prevalence of heavy menstrual bleeding and associations with physical health and wellbeing in low-income and middle-income countries: a multinational cross-sectional study","volume":"11","author":"Sinharoy","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jtha.2025.08.012_bib37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4067\/S0370-41062017000600717","article-title":"[Heavy menstrual bleeding affects quality of life in adolescents]","volume":"88","author":"Torres","year":"2017","journal-title":"Rev Chil Pediatr"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625005379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625005379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:59:42Z","timestamp":1766152782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625005379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1538783625005379"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.08.012","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interdisciplinary management of gynecologic bleeding with anticoagulation: a recommended toolkit from the Foundation for Women and Girls with Blood Disorders+ Thrombosis Subcommittee","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}